Dilution is not the issue for the reasons outlined in my previous post. With this type of biotech speculative stock its the fickle market that decides the price at any given time. The market knows there is potential dilution to the limit of that covered by the spp but that needs to be weighed up against the positive of being financially secure versus the negative of dilution. Its a twofold thing and the market will ultimately decide. There is no formula that will predict the dilution impact.
cheers
trading analysis is prr positive, page-11
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |